Paul A Friedman

Director

Paul A Friedman (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $13.6M of MDGL (24,640 sh across 8 lots, as filed), executed Dec 10 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$26.3M

shares × price, as filed

Last traded

Jan 9

Filed Jan 13

Median ADV $194.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $101.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

MDGL

Madrigal Pharmaceuticals, Inc. MDGL · 0 buys · 7 sells 7 filings

Recent filings

MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $12.5M
24,006 sh across 23 lots
Exec Jan 9
Filed Jan 13 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $154K
280 sh × $551.24
Exec Jan 9
Filed Jan 13 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $13.6M
24,640 sh across 8 lots
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $47.8M
129,172 sh across 17 lots
Exec Aug 13 2025
Filed Aug 13 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $16.6M
46,808 sh across 12 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $490K
1,400 sh × $350.03
Exec Jul 18 2025
Filed Jul 22 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $10.2M
28,876 sh across 9 lots
Exec Jul 16 2025
Filed Jul 18 2025 · 5:30 PM ET